Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

U.S. Cerebral Palsy Treatment Market was valued at USD 1.17 billion in 2024 and is estimated to grow at a CAGR of 3.2% to reach USD 1.60 billion by 2034. This projected growth is fueled by a rising nu...

According to Stratistics MRC, the Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market is accounted for $26209.70 million in 2025 and is expected to reach $48220.90 million by 2032...

The global multiple sclerosis therapies market size reached USD 27.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 38.8 Billion by 2033, exhibiting a growth rate (CAGR)...

The global neurodegenerative disease treatment market size reached USD 78.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 118.5 Billion by 2033, exhibiting a growth rat...

... global market for anti-Parkinson’s drugs and their future demand Analyses of global market trends, with ... printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs ...

According to Stratistics MRC, the Global ADHD Therapeutics Market is accounted for $38.3 billion in 2025 and is expected to reach $70.5 billion by 2032 growing at a CAGR of 9.09% during the forecast p...

According to Stratistics MRC, the Global Neuroplasticity Enhancement Solutions Market is accounted for $8.39 billion in 2025 and is expected to reach $50.15 billion by 2032 growing at a CAGR of 29.1%...

This report can be delivered to the clients within 2 Business Days U.S. Attention Deficit Hyperactivity Disorder Market The U.S. attention deficit hyperactivity disorder market size was estimated at...

The Epilepsy Drugs Market was valued at US$ 11.09 Billion in 2024 and is anticipated to reach US$ 16.73 Billion by 2033, at a CAGR of 0.042 from 2026 to 2032. The report delivers in-depth insights int...

The Cerebral Palsy Treatment Market was valued at US$ 2.92 Billion in 2024 and is anticipated to reach US$ 5.13 Billion by 2033, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insi...

: This report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimer’s disease. It includes global revenue ($ million) for base year data of 2024, esti...

The Divalproex Sodium Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...

Market Overview According to DIResearch's in-depth investigation and research, the global Benzobarbital API market size will reach 4.48 Million USD in 2025 and is projected to reach 5.71 Million USD...

Market Overview According to DIResearch's in-depth investigation and research, the global Trazodone Hydrochloride (API) market size will reach Million USD in 2025 and is projected to reach Million U...

The Huntington's Disease Market was valued at US$ 455.65 million in 2024 and is anticipated to reach US$ 3,230.84 million by 2033, at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth in...

The Disruptive Behavior Disorder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.053 from 2026 to 2032. The report delivers in-depth insights into key market dynamics...

The USA Opioids Drug Market was valued at US$ 9.58 billion in 2023 and is anticipated to reach US$ 13.02 billion by 2031, at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights int...

The Frontotemporal Disorders Treatment Market was valued at USD 721.4 million in 2021 and is anticipated to reach by , at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insights into...

The Neuropathic Pain Market was valued at US$ 8.44 Billion in 2024 and is anticipated to reach US$ 18.45 Billion by 2033, at a CAGR of 0.089 from 2026 to 2032. The report delivers in-depth insights in...

The Global VMAT2 Inhibitors Market was valued at USD 5 billion in 2024 and is estimated to grow at a CAGR of 9.6% to reach USD 12.3 billion by 2034, driven by the growing incidence of movement-related...

The Psychedelic Drugs Market was valued at US$ 3.31 Billion in 2024 and is anticipated to reach US$ 9.20 Billion by 2033, at a CAGR of 0.121 from 2026 to 2032. The report delivers in-depth insights in...

The Amyotrophic Lateral Sclerosis (ALS) Market was valued at US$ 0.82 billion in 2024 and is anticipated to reach US$ 1.22 billion by 2033, at a CAGR of 0.051 from 2026 to 2032. The report delivers in...

The Global Bipolar Disorder Treatment Market was valued at US$ 5.80 billion in 2024 and is anticipated to reach US$ 9.75 billion by 2033, at a CAGR of 0.06 from 2026 to 2032. The report delivers in-de...

The Neuroleptic Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...

The Ziprasidone Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...

The global cognitive and memory enhancer drugs market size reached USD 6,171.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 9,460.6 Million by 2033, exhibiting a growt...

The global depression drugs market size reached USD 19.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2033, exhibiting a growth rate (CAGR) of 2.9% dur...

The Anti Depression Drugs Market was valued at US$ 15.81 billion in 2023 and is anticipated to reach US$ 22.10 billion by 2031, at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insig...

According to Stratistics MRC, the Global Neuropathic Pain Market is accounted for $8.24 billion in 2024 and is expected to reach $14.35 billion by 2030 growing at a CAGR of 9.7% during the forecast pe...

The Learning Disabilities Treatment Market was valued at US$ 11.07 billion in 2024 and is anticipated to reach US$ 19.62 billion by 2032, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-d...

The Schizophrenia Drugs Market was valued at US$ 10.03 billion in 2024 and is anticipated to reach US$ 15.58 billion by 2032, at a CAGR of 0.057 from 2026 to 2032. The report delivers in-depth insight...

Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Ch...

The pregabalin market was valued at $1.6 billion in 2022 and is estimated to reach $2.2 billion by 2032, exhibiting a CAGR of 3% from 2023 to 2032. Pregabalin belongs to a group of drugs known as anti...

... : Global GABA Drugs Market Analysis by Dosage & Price Promising GABA Receptor Agonist Therapeutics Trends and Market Dynamics of GABA Receptor Agonist Global GABA Receptor Agonists Clinical Pipeline = 49 Drugs Marketed Global GABA Receptor Agonists Clinical Insight = 28 Drugs GABA Receptor Agonist Market ...

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. This report will be delivered in 7-10 workin...

The global cervical dystonia market is witnessing steady expansion, driven by rising disease prevalence, advancements in neuromodulation techniques, and increased awareness surrounding movement disord...

The global Friedreich’s ataxia market is witnessing significant growth driven by advancements in genetic research, increasing diagnostic capabilities, and rising awareness of this rare hereditary neur...

The global Guillain-Barre syndrome market is witnessing significant growth, driven by advancements in treatment options, increased awareness of autoimmune disorders, and a rising demand for effective...

The global autoimmune encephalitis market is experiencing significant growth, primarily driven by the increasing prevalence of autoimmune diseases, increasing awareness and advancements in diagnostic...

The global developmental and epileptic encephalopathies market is projected to expand significantly from 2024 to 2035, reflecting a steady compound annual growth rate (CAGR) over the forecast period....

Schizoaffective disorder is a chronic mental health condition characterized by a combination of schizophrenia symptoms, such as hallucinations and delusions, alongside mood disorder symptoms, includin...

Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, including the brain, spinal cord, and optic nerves. In MS, the immune system attacks myelin the protective...

The Obsessive-Compulsive Disorder (OCD) market is a rapidly evolving sector, driven by increasing awareness, improved diagnostic rates, and the growing adoption of both pharmacological and device-base...

The global circadian rhythm disorders market is experiencing robust growth due to increasing awareness of sleep disorders and advancements in treatment options. Circadian rhythm disturbances, includin...

Cocaine intoxication refers to the acute physiological and psychological effects that occur when an individual consumes cocaine, a potent central nervous system stimulant. Cocaine works by blocking th...

The global hemiplegia market was valued at a substantial level in 2024 and is projected to expand significantly by 2035, reflecting a steady compound annual growth rate over the forecast period. Growt...

The Generalized Anxiety Disorder (GAD) market is evolving significantly, driven by a variety of factors. One of the primary trends is the rising prevalence and awareness of mental health issues, inclu...

The Chronic Focal Epilepsy (CFE) market is a dynamic segment within the broader epilepsy treatment landscape, driven by advancements in diagnostics, therapeutics, and patient management. Focal epileps...